Back to News
Market Impact: 0.35
CVS Agrees To Pay $315 Mln To Resolve Opioid Prescription Allegations
Source: Nasdaq
Legal & LitigationHealthcare & BiotechRegulation & LegislationCompany Fundamentals
CVS Pharmacy and related CVS Health entities agreed to pay $315 million to settle federal allegations involving unlawful dispensing of opioids and other controlled substances and false claims to federal healthcare programs. The report describes allegations settled, not a finding of liability.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.40
Ticker Sentiment
CVS-0.80
More News
- Jim Cramer says this healthcare stock is still a buy. Plus, what to do with BNY
- Anthropic's third-quarter revenue is said to hit $16.8 billion ahead of IPO
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- UBS considers leaving Switzerland over capital rule plans, WSJ reports
- US Stocks Tumble as Chip Rout Deepens
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Tools for CFA Charterholders: An Evidence Standard
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data